Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/28/2012CA2453337C Methods and materials for the treatment of testosterone deficiency in men
08/28/2012CA2437812C Compositions and methods for modulation of vascular structure and/or function
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2389345C Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/25/2012CA2733732A1 Formulations of canfosfamide and their preparation
08/23/2012WO2012112982A2 Hydrogel encapsulated cells and anti-inflammatory drugs
08/23/2012WO2012112952A1 Technology for preventing abuse of solid dosage forms
08/23/2012WO2012112767A2 Collagen-targeted nanoparticles
08/23/2012WO2012112566A1 Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea
08/23/2012WO2012112531A1 Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
08/23/2012WO2012112437A1 Filmcoated solid dosage forms comprising honey in the coating
08/23/2012WO2012112355A1 Methods for controlling pain in equines using a transdermal solution of fentanyl
08/23/2012WO2012112348A1 Methods for controlling pain in canines using a transdermal solution of fentanyl
08/23/2012WO2012112140A1 Extended release powder and aqueous suspension comprising methylphenidate
08/23/2012WO2012111996A2 Transdermal delivery system containing galantamine or salts thereof
08/23/2012WO2012111965A2 Orally administered sustained-release triple-layer pill containing tamsulosin or pharmaceutically acceptable salt thereof
08/23/2012WO2012111961A2 Orally administrated sustained-release tablet containing tianeptine or pharmaceutically acceptable salt thereof
08/23/2012WO2012111762A1 Highly concentrated anti-cd40 antibody pharmaceutical preparation
08/23/2012WO2012111627A1 Nanoparticle containing prostaglandin i2 derivative
08/23/2012WO2012111024A1 Pharmaceutical compositions of dexlansoprazole
08/23/2012WO2012110971A2 Method and composition to retard sorption of preservatives to plastics
08/23/2012WO2012110912A1 Sustained release composition of memantine
08/23/2012WO2012110886A1 Controlled-release formulation comprising hcg
08/23/2012WO2012110631A1 Pharmaceutical formulation for topical administration comprising b220
08/23/2012WO2012110471A1 Cefuroxime safety delivery system
08/23/2012WO2012110469A1 A process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
08/23/2012WO2012110462A1 Liquid propellant-free formulation comprising an antimuscarinic drug
08/23/2012WO2012110456A1 Absorbent dressings with painkilling activity
08/23/2012WO2012110430A1 Novel composition for topical use on a nail
08/23/2012WO2012110222A1 Rapidly disintegrating oral film formulation for olanzapin
08/23/2012WO2012110092A1 Tamsulosin derivatives
08/23/2012WO2012110057A1 Cefuroxime safety kit
08/23/2012WO2012109976A1 Use of α-mangostin in preparation of medicaments for treating alzheimer's disease
08/23/2012WO2012109694A1 Process for preparing products comprising stabilised actives and compositions comprising same
08/23/2012WO2012109685A1 Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas
08/23/2012WO2012092504A3 Nanoparticle and surface-modified particulate coatings, coated balloons, and methods therefore
08/23/2012WO2012091518A3 Phospholipid nanoparticles for mr-induced high-intensity focused ultrasonic treatment and diagnosis, and method for producing same
08/23/2012WO2012087062A3 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
08/23/2012WO2012085249A3 Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
08/23/2012WO2012083017A3 Controlled release oral dosage forms of poorly soluble drugs and uses thereof
08/23/2012WO2012081905A3 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
08/23/2012WO2012078121A3 Solid oral dosage form comprising cefdinir
08/23/2012WO2012075447A3 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
08/23/2012WO2012075337A3 Agent delivery systems for selective neuromodulation
08/23/2012WO2012075015A3 Oral metronidazole pharmaceutical compositions
08/23/2012WO2012074440A3 Pharmacological composition intended for intra-nasal administration with the aim of supplying a pharmacologically active component to the brain, and method for producing said composition
08/23/2012WO2012074245A3 Mineral composition, and preparation method thereof
08/23/2012WO2012072692A3 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
08/23/2012WO2012066506A3 Method for fabricating a microneedle
08/23/2012WO2012055947A3 Preparation of orodispersible films
08/23/2012WO2012042446A3 Fibres and relative woven and non woven tissues for the topic treatment of sexual dysfunctions of the male genital apparatus
08/23/2012WO2012012541A3 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY
08/23/2012WO2011163483A3 Polymers for biomaterials and therapeutics
08/23/2012WO2011154295A4 Medical device having a counter having a preset counting range, device having counter variation
08/23/2012US20120216304 Humanized animals via tissue engineering and uses thereof
08/23/2012US20120215185 Transdermal delivery system for the administration of rotigotine
08/23/2012US20120214951 Preparation of polyphosphazene microspheres
08/23/2012US20120214773 Formulation for lipophilic agents
08/23/2012US20120214749 Microparticles comprising somatostatin analogues
08/23/2012US20120213857 Method for Producing Pancreatin Pellets
08/23/2012US20120213856 Manufacturing Method of Microcapsule
08/23/2012US20120213855 Dosage forms for weakly ionizable compounds
08/23/2012US20120213854 Methods of treating a subject and related particles, polymers and compositions
08/23/2012US20120213853 Compositions and improved soft tissue replacement methods
08/23/2012US20120213852 Compositions and improved soft tissue replacement methods
08/23/2012US20120213851 Solid pharmaceutical compositions containing an integrase inhibitor
08/23/2012US20120213850 Controlled Release and Taste Masking Oral Pharmaceutical Composition
08/23/2012US20120213849 Calcium carbonate granulation
08/23/2012US20120213848 Treatment of Infection Using Single Chain Antibody Gene Therapy
08/23/2012US20120213847 Microporous zirconium silicate for the treatment of hyperkalemia
08/23/2012US20120213846 Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration
08/23/2012US20120213845 Skin composition comprising an exfoliate, a brightener and a collagen booster, and method of using the same
08/23/2012US20120213844 Liposome composition for targeting egfr receptor
08/23/2012US20120213842 Methods of making and using compositions comprising flavonoids
08/23/2012US20120213839 Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
08/23/2012US20120213838 Medical device for placement into a lumen and manufacturing method thereof
08/23/2012US20120213837 Compositions and methods for bioactive coatings to improve allograft incorporation
08/23/2012US20120213834 Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
08/23/2012US20120213833 Prevotella histicola preparations and the treatment of autoimmune conditions
08/23/2012US20120213832 Removable dental curable composition
08/23/2012US20120213831 Microspheres for active embolization
08/23/2012US20120213830 Suspension comprising benzimidazole carbamate and a polysorbate
08/23/2012US20120213829 Dry powder aerosols of nanoparticulate drugs
08/23/2012US20120213828 Adenovirus vaccine vector and methods of use
08/23/2012US20120213827 Process for controlled crystallization of an active pharmaceutical ingredient from supercooled liquid state by hot melt extrusion
08/23/2012US20120213826 Use of Pro-Inflammatory Compounds for Promoting Bone Formation
08/23/2012US20120213825 Antibiotic product, use and formulation thereof
08/23/2012US20120213804 Calicheamicin derivative-carrier conjugates
08/23/2012US20120213713 Compositions of omega fatty acids for the prevention and treatment of dental caries resulting from oral infections
08/23/2012US20120213712 Cosmetic composition in the foam form
08/23/2012US20120213711 Compositions Containing A Solvated Active Agent Suitable For Dispensing As A *** Gas Aerosol
08/23/2012US20120213710 Non Surface Active Agent Non Polymeric Agent Hydro-Alcoholic Foamable Compositions, Breakable Foams and Their Uses
08/23/2012US20120213709 Non Surfactant Hydro-Alcoholic Foamable Compositions, Breakable Foams and Their Uses
08/23/2012US20120213708 Hydrogel encapsulated cells and anti-inflammatory drugs
08/23/2012US20120213707 Riboflavin Based Aerosol and Use as Placebo in Trials
08/23/2012US20120213697 Versatile nanoparticulate biomaterial for controlled delivery and/or containment of therapeutic and diagnostic material
08/23/2012US20120211007 Inhaler for the administration of an anticholinergic
08/23/2012US20120211005 Pulmonary delivery of alpha-1 proteinase inhibitor
08/23/2012DE102011011889A1 Device, useful for the continuous production of cut moldings, comprises extruder for generating extrudate, filler-containing extrudate strand, conveyor downstream to extruder, cutting device, and tempering zone
08/23/2012DE102011011092A1 Gelierendes Kollagen und Mittel zu dessen Bereitstellung Gelling collagen and means for its provision
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 2991